惠斯安普HRA品牌怎么样 申请店铺

我要投票 惠斯安普HRA在医疗器械行业中的票数:16 更新时间:2024-11-22
惠斯安普HRA是哪个国家的品牌?「惠斯安普HRA」是 秦皇岛市惠斯安普医学系统股份有限公司 旗下著名品牌。该品牌发源于河北省秦皇岛市,由创始人陈董在2011年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
惠斯安普HRA怎么样

秦皇岛市惠斯安普医学系统股份有限公司,成立于2011年,是一家专注于生物医学领域医疗设备及系统的设计、开发、生产及销售为一体的企业。公司拥有生物医学领域的博士、硕士专业研发人才50余名;与国内外多家生物医学研究机构、高等院校和医院建立了稳定的合作关系,并设有电磁干扰与静电防护院士工作站、生物医学研究中心和生物医学体验中心。

惠斯安普医学系统股份有限公司紧密围绕国家“战略前移,重心下移”的人口与健康科技发展战略方针,努力在国民健康管理产业发展中开拓自己的成长空间,先后研制成功HRA疾病早期筛查及健康风险评估、ADDS阿尔茨海默病早期筛查及诊断、ADTS记忆力障碍训练系统、PMR脉冲磁共振微循环修复等“全链式”健康管理适宜技术设备,构建了覆盖“医院前“和”医院后”细分市场的疾病早期筛查评估、健康风险干预、功能康复全产品线。

目前,惠斯安普产品用户已遍及国内32个省、市、区。惠斯安普医学系统股份有限公司已与中国健康促进基金会、清华大学、北京大学结成战略合作伙伴关系,在国内联合开展以HRA应用研究和国民健康云数据计划为核心内容的健康管理工程,加速了HRA在国家健康管理示范基地及其旗舰单位、高校和体育运动系统的推广,使更广大的人群从中受益。

发展历程:

2011年

4月 惠斯安普医学公司正式成立;

7月 受邀参展由国家科技部参加了国家十一五重大科技成果展;

2013年

5月 HRA健康风险评估设备取得中华人民共和国医疗器械注册证;

7月 HRA健康风险评估设备参加澳门科技周活动;

2014年

4月 惠斯安普公司与清华大学联合发起的国民“健康云数据”计划正式启动;

11月 中国高校师生健康促进联盟在京成立,HRA成为国内高校师生健康数据釆集专用设备;

2015年

3月 惠斯安普成为中国人民解放军总后勤部物资采购供应商;

4月 惠斯安普与中国健康促进基金会合作的“HRA多中心应用研究项目”正式启动;

2016年

8月 惠斯安普公司正式挂牌新三板,股票代码838857;

2017年

1月 HRA健康风险评估快速体检车在秦皇岛惠斯安普下线;

9月 惠斯安普获批成立省级科技专家企业工作站;

2018年

10月 惠斯安普与阿里健康签署战略合作协议,共同开启“应用人工智能黑科技HRA,开展区域人群健康风险评估管理”计划。


Qinhuangdao Huisi Anpu Medical System Co., Ltd., founded in 2011, is an enterprise focusing on the design, development, production and sales of medical equipment and systems in the biomedical field. The company has more than 50 doctoral and master's R & D talents in biomedical field. It has established stable cooperation with many biomedical research institutions, colleges and hospitals at home and abroad, and has academician workstation for electromagnetic interference and electrostatic protection, biomedical research center and biomedical experience center. Based on the national strategy of population and health science and technology development, wisanpu Medical System Co., Ltd. strives to develop its own growth space in the development of national health management industry. It has successively developed the Department of early screening and health risk assessment of HRA disease, early screening and diagnosis of Alzheimer's disease, and training of ADTs memory impairment The "whole chain" health management appropriate technology and equipment, such as unifying and PMR pulse magnetic resonance microcirculation repair, has constructed the whole product line of disease early screening assessment, health risk intervention and functional rehabilitation covering the "pre hospital" and "post hospital" market segments. At present, the products of wisanp have been used in 32 provinces, cities and districts in China. Wisanpu Medical System Co., Ltd. has formed strategic partnership with China health promotion foundation, Tsinghua University and Peking University to jointly carry out the health management project with HRA application research and national health cloud data plan as the core content in China, accelerating the promotion of HRA in the national health management demonstration base and its flagship units, universities and sports systems To benefit the wider population. Development history: in April 2011, wisanp medical company was officially established; in July, it was invited to participate in the national 11th five year major scientific and technological achievements exhibition by the Ministry of science and technology of the people's Republic of China; in May 2013, HRA health risk assessment equipment obtained the registration certificate of medical devices of the people's Republic of China; in July, HRA health risk assessment equipment participated in Macao science and technology week; in April 2014, wisanp medical company and Tsinghua University jointly participated The national "health cloud data" plan launched officially; in November, the health promotion alliance of teachers and students of Chinese universities was established in Beijing, HRA has become a special equipment for health data collection of teachers and students in Colleges and universities in China; in March 2015, Huis amp became a material procurement supplier of the General Logistics Department of the people's Liberation Army; in April, the "HRA multi center application research project" cooperated by Huis amp and China health promotion foundation was officially launched; in August 2016, Huis amp officially launched the new third board, Stock Code: 838857; in January 2017, the HRA health risk assessment rapid physical examination vehicle was offline in Huisi Anpu, Qinhuangdao; in September, Huisi Anpu was approved to establish a provincial science and technology expert enterprise workstation; in October 2018, Huisi Anpu and Ali health signed a strategic cooperation agreement to jointly launch the plan of "applying human industry intelligent black technology HRA to carry out regional population health risk assessment management".

本文链接: https://brand.waitui.com/1b66b8b94.html 联系电话:400-619-0125

千城特选小程序码

7×24h 快讯

私募购买年内上市ETF近30亿份

私募排排网统计数据显示,截至11月22日,共有126家私募证券管理人旗下产品进入到107家年内上市ETF前十大持有人名单中,合计持有份额达29.57亿份。(界面)

31分钟前

外交部:进一步扩大免签国家范围并优化入境政策

36氪获悉,据外交部领事司,为进一步便利中外人员往来,中方决定扩大免签国家范围,自2024年11月30日起至2025年12月31日,对保加利亚、罗马尼亚、克罗地亚、黑山、北马其顿、马耳他、爱沙尼亚、拉脱维亚、日本持普通护照人员试行免签政策。此外,中方决定同步优化入境政策,将交流访问纳入免签事由,将免签停留期限自现行15日延长至30日。自2024年11月30日起,包括上述9国在内的38个免签国家持普通护照人员来华经商、旅游观光、探亲访友、交流访问、过境不超过30天,可免办签证入境。不符合免签条件人员仍需在入境前办妥来华签证。

31分钟前

中国汽车流通协会:预计11月狭义乘用车零售市场约为240万辆

36氪获悉,据中国汽车流通协会,最新调研结果显示,11月月中整体车市折扣率约为24.1%,环比上月基本持平,终端优惠及促销政策力度无明显变化。零售量占总市场近八成的头部厂商本月零售目标环比增幅约6.5%,初步推算本月狭义乘用车零售总市场规模约为240.0万辆左右,同比去年增长15.4%,环比上月增长6.1%,新能源零售预计可达128.0万,渗透率约53.3%。

31分钟前

越南电动车商VinFast母公司成立机器人研发应用企业VinRobotics

当地时间11月20日,越南电动车商VinFast母公司Vin集团宣布成立“VinRobotics机器人研发与应用股份公司”,法定资本为10万亿越南盾(约合4000万美元)。Vin集团持有新公司51%的股份,Vin集团创始人范日旺持股39%。(界面)

31分钟前

康为世纪:幽门螺杆菌耐药基因检测试剂盒获得III类医疗器械注册证

36氪获悉,康为世纪发布公告,全资子公司健为诊断自主研发生产的幽门螺杆菌耐药基因检测试剂盒(基于粪便样本)收到国家药品监督管理局颁发的III类《医疗器械注册证》。

31分钟前

本页详细列出关于诚益通的品牌信息,含品牌所属公司介绍,诚益通所处行业的品牌地位及优势。
咨询